NCT05330000View on ClinicalTrials.gov

Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 22, 2020

Primary Completion Date

July 8, 2020

Study Completion Date

September 16, 2020

Conditions
Healthy Adults
Interventions
DRUG

4 mg/kg Voriconazole

Low dose group: 24 healthy adult subjects are planned to be enrolled. Intravenous drip Voriconazole for injection in fasting state per cycle. The dosage was 4 mg / kg for 80 min.

DRUG

6 mg/kg Voriconazole

High dose group: 24 healthy adult subjects are planned to be enrolled. Intravenous drip Voriconazole for injection in fasting state per cycle. The dosage was 6 mg / kg for 120 min.

Trial Locations (1)

266003

Phase I Clinical Research Center, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER

NCT05330000 - Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects | Biotech Hunter | Biotech Hunter